Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Fischer

Showing results (461-470 of 490) with videos related to

Pageof 49
Sort By:
The Journal of Clinical Investigation|July 20, 2018
JAK2-V617F promotes venous thrombosis through β1/β2 integrin activationBärbel Edelmann, Nibedita Gupta, Tina M Schnoeder, et al.
Nature|December 2, 2008
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblastsThomas Thum, Carina Gross, Jan Fiedler, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|January 12, 2026
EFSUMB Testis Multiparametric Ultrasound GuidelinesMichele Bertolotto, Simon Freeman, Dean Huang, et al.
Nature Communications|August 23, 2017
Activated protein C protects from GvHD via PAR2/PAR3 signalling in regulatory T-cellsSatish Ranjan, Alexander Goihl, Shrey Kohli, et al.
Frontiers in Neurology|November 9, 2023
Implementing stroke care in a lower-middle-income country: results and recommendations based on an implementation study within the Nepal Stroke ProjectChristine Tunkl, Raju Paudel, Sunanjay Bajaj, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2013
Sorafenib in combination with intensive chemotherapy in elderly patients with acute myeloid leukemia: results from a randomized, placebo-controlled trialHubert Serve, Utz Krug, Ruth Wagner, et al.
Journal of the American Heart Association|April 26, 2022
Diagnostic Yield of Genetic Testing in Young Patients With Atrioventricular Block of Unknown CauseJohnni Resdal Dyssekilde, Tanja Charlotte Frederiksen, Morten Krogh Christiansen, et al.
British Journal of Haematology|September 30, 2017
Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trialHermann Einsele, Monika Engelhardt, Christoph Tapprich, et al.
The New England Journal of Medicine|March 15, 2003
Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemiaStephen G O'Brien, François Guilhot, Richard A Larson, et al.
Blood|March 6, 2002
Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 studyMoshe Talpaz, Richard T Silver, Brian J Druker, et al.
Pageof 49

Showing results (461-470 of 490) with videos related to

Sort By:
Pageof 49
The Journal of Clinical Investigation|July 20, 2018
JAK2-V617F promotes venous thrombosis through β1/β2 integrin activationBärbel Edelmann, Nibedita Gupta, Tina M Schnoeder, et al.
Nature|December 2, 2008
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblastsThomas Thum, Carina Gross, Jan Fiedler, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|January 12, 2026
EFSUMB Testis Multiparametric Ultrasound GuidelinesMichele Bertolotto, Simon Freeman, Dean Huang, et al.
Nature Communications|August 23, 2017
Activated protein C protects from GvHD via PAR2/PAR3 signalling in regulatory T-cellsSatish Ranjan, Alexander Goihl, Shrey Kohli, et al.
Frontiers in Neurology|November 9, 2023
Implementing stroke care in a lower-middle-income country: results and recommendations based on an implementation study within the Nepal Stroke ProjectChristine Tunkl, Raju Paudel, Sunanjay Bajaj, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2013
Sorafenib in combination with intensive chemotherapy in elderly patients with acute myeloid leukemia: results from a randomized, placebo-controlled trialHubert Serve, Utz Krug, Ruth Wagner, et al.
Journal of the American Heart Association|April 26, 2022
Diagnostic Yield of Genetic Testing in Young Patients With Atrioventricular Block of Unknown CauseJohnni Resdal Dyssekilde, Tanja Charlotte Frederiksen, Morten Krogh Christiansen, et al.
British Journal of Haematology|September 30, 2017
Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trialHermann Einsele, Monika Engelhardt, Christoph Tapprich, et al.
The New England Journal of Medicine|March 15, 2003
Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemiaStephen G O'Brien, François Guilhot, Richard A Larson, et al.
Blood|March 6, 2002
Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 studyMoshe Talpaz, Richard T Silver, Brian J Druker, et al.
Pageof 49